Sensex, Nifty Trade Flat; Metal, Pharma Stocks Top Drags
The domestic stock markets swung between gains and losses in Tuesday's session after the US said it was likely to go ahead with a tariff hike on Chinese goods. Investors are also cautious ahead of the expiry of futures and options (F&O) contracts on Thursday and the release of the gross domestic product data for the September quarter on Friday. At 12:31 pm, the S&P BSE Sensex traded at 35,317.55, with a loss of 36.53 points or 0.10 per cent while the Nifty50 index of the National Stock Exchange (NSE) was at 10,619.10, down 9.50 points or 0.09 per cent.
Twenty six out of 50 Nifty stocks traded in the red led by losses in metal and pharma stocks. Nifty Metal - the index of metal stocks - and Nifty Pharma - the index of pharma stocks - lost 2.34 per cent and 1.27 per cent respectively.
Losing between 2.30 per cent and 5.30 per cent, Sun Pharma, JSW Steel, Tata Steel, Hero MotoCorp and Bajaj Auto were the top drags in the Nifty pack.
"Market stays in a tight range, investors wouldn't feel comfortable about results of the past quarter given the volatility of the earnings," news agency Reuters reported Deven Choksey, founder, KR Choksey Investment Managers, as saying.
"Volatility increased in the F&O market yesterday and that's a cause for worry. Volatility is significantly increasing in the monthly settlement along with the open interest," he added.
However, technical experts spotted a buying opportunity. "As depicted in the lower time frame chart - mainly on the hourly chart - the RSI (Relative Strength Index) had posted a hidden divergence wherein RSI is making a lower low but price chart is not making a lower low. This indicates a buying opportunity. The intermediate support is placed near the 10,500 mark," said Dyaneshwar Padwal, AVP Technical Analyst, KIFS Trade Capital. RSI is a technical indicator used in stock markets to measure the speed and change of movements.
In global markets, Asian share markets were generally muted but Japan's Nikkei managed to add 0.8 per cent and Chinese blue-chips rose 0.4 per cent.
MSCI's broadest index of Asia-Pacific shares outside Japan dithered either side of flat and was last up 0.2 per cent.
In commodity markets, oil prices laboured with record production by Saudi Arabia. US crude was off 9 cents at $51.54 a barrel, while Brent futures inched up 3 cents to $60.51.
On Monday, foreign portfolio investors and domestic institutional investors bought net equities worth Rs 62.74 crore and Rs 351.78 crore respectively, showed provisional NSE data. In the last session, the Sensex had closed at 35,354.08 and the Nifty at 10,628.60.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.
-
When Everyone Has AI, What Gives You An Edge?
India's young workforce is entering an uncertain world of work where powerful AI tools are becoming widely accessible. The advantage will belong to those who combine deep expertise with digital fluency, and the distinctly human capabilities that technology cannot manufacture.